Fred Tejada Secures Board Seat at Nu-Med Plus with 9.7% Stake
Fred Tejada disclosed a 9.7% stake in Nu-Med Plus, Inc. (NUMD), gaining a board seat and significant voting power. He entered a Voting Agreement to influence corporate actions, including a reverse stock split and board restructuring. Tejada's super-voting shares and proxy control key shareholder votes.
How this was made
The 30-second read
Why it matters
The filing introduces a new major shareholder with voting power, likely influencing future corporate decisions such as the proposed reverse split and name change.
Market read
Primary disclosure of a large insider stake and governance change; modest trading relevance for micro‑cap investors.
What to watch
Potential upcoming reverse split and redomiciling could affect liquidity and valuation.
Background
Nu-Med Plus Inc. filed a Schedule 13D after acquiring Avid Gold Ltd., introducing a new board member with a sizable equity position.
Ticker impact
Fred Tejada disclosed a 9.7% stake and secured a board seat via a Schedule 13D filing.
Potential modest upside as investors view increased insider confidence, but volatility may rise.
The 13D filing is a primary source disclosure of a large stake and governance change, which can shift market sentiment.
Market effects
May signal increased interest in resource-focused companies.
Limited to US micro‑cap investors.
Low
Counterpoint
The stake could be a strategic move to influence a turnaround, but may not translate to immediate price gains.
Key entities
- individualFred Tejada
Canadian geologist, now senior vice president, chief geologist, and board member of Nu-Med Plus.
- companyNu-Med Plus Inc.
Resource-focused company that recently acquired Avid Gold Ltd.
